Funds and ETFs Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2024-05-23 pm EDT 5-day change 1st Jan Change
43.17 USD -0.76% Intraday chart for Qiagen N.V. -6.13% -3.58%

ETFs positioned on Qiagen N.V.

Name Weight AuM 1st Jan change Investor Rating
3.10% 1 M€ 0.00% -
1.79% 2 M€ -.--%
1.65% 2 M€ 0.00%
1.32% 144 M€ +1.52% -
1.08% 8 M€ 0.00%
0.91% 0 M€ 0.00% -
0.85% 14 M€ -3.15%
0.81% 962 M€ -.--% -
0.74% 2 M€ -25.75%
0.62% 7 M€ -.--% -
0.38% 17 M€ +7.18% -
0.17% 1,083 M€ +3.43%
0.14% 6 M€ -.--% -
0.08% 6 M€ -.--%
0.06% 10 M€ -3.35% -
0.06% 8 M€ +7.26% -
0.06% 744 M€ +10.58%
0.04% 32 M€ +6.91% -
0.02% 23 M€ -.--% -
0.02% 786 M€ -.--%
0.02% 206 M€ -.--%
0.02% 283 M€ +20.80%
0.02% 284 M€ -.--%
0.02% 205 M€ -.--%
0.02% 607 M€ +0.05% -
0.02% 1,166 M€ +0.26% -
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.17 USD
Average target price
50.14 USD
Spread / Average Target
+16.14%
Consensus
  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. Funds and ETFs Qiagen N.V.